Intech Investment Management LLC Cuts Stock Position in Colgate-Palmolive Company $CL

Intech Investment Management LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 5.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 677,014 shares of the company’s stock after selling 42,155 shares during the quarter. Colgate-Palmolive accounts for approximately 0.5% of Intech Investment Management LLC’s holdings, making the stock its 27th biggest position. Intech Investment Management LLC’s holdings in Colgate-Palmolive were worth $54,121,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CL. Fox Run Management L.L.C. acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $1,733,000. MAI Capital Management raised its holdings in Colgate-Palmolive by 6.8% during the third quarter. MAI Capital Management now owns 48,974 shares of the company’s stock worth $3,915,000 after purchasing an additional 3,129 shares in the last quarter. Waddell & Associates LLC lifted its position in Colgate-Palmolive by 4.5% in the third quarter. Waddell & Associates LLC now owns 3,763 shares of the company’s stock valued at $301,000 after purchasing an additional 163 shares during the period. Colonial Trust Co SC boosted its holdings in Colgate-Palmolive by 12.4% in the 3rd quarter. Colonial Trust Co SC now owns 5,501 shares of the company’s stock valued at $440,000 after purchasing an additional 605 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $318,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Investor visibility: Colgate will webcast a fireside chat at the UBS Global Consumer & Retail Conference (March 11). Management access and the Q&A may provide clarity on growth plans and could support the stock if management delivers reassuring execution or guidance. Colgate-Palmolive Webcasts Fireside Chat at the UBS Global Consumer and Retail Conference 2026
• Positive Sentiment: Momentum/technical improvement: Coverage notes that CL is up strongly year-to-date and recently received a Relative Strength rating upgrade, which can attract momentum investors and support the share price. Colgate-Palmolive Stock Up 23% So Far This Year, Shines Brightly. Gets Rating Upgrade.
• Neutral Sentiment: Peer/comparative coverage: Multiple write-ups compare CL versus peers like Procter & Gamble on growth, margins and valuation — useful context for investors sizing relative upside but not an immediate catalyst. Procter & Gamble vs. Colgate: Which Consumer Stock Has More Upside?
• Neutral Sentiment: Industry backdrop: A new market report highlights long-term growth in beauty/personal-care markets and lists Colgate among major players — a positive structural tailwind but not an immediate stock mover. Global Cosmetics Market Competitive Landscape Report 2025
• Negative Sentiment: Execution risk flagged: Analysts note newly disclosed execution risks tied to Colgate’s three-year strategic growth and productivity program — risks to delivery could pressure sentiment if targets slip. Execution Risks Loom Over Colgate-Palmolive’s 3-Year Strategic Growth and Productivity Program
• Negative Sentiment: Governance/debate over DEI: Colgate is publicly defending DEI criteria for board selection against a shareholder proposal, which creates proxy-season noise and potential reputational or governance risk. Colgate-Palmolive plans to defend DEI criteria for board selection, letter shows
• Negative Sentiment: Options activity: Unusual put buying (notably higher-than-average volume) suggests some investors are hedging or betting on downside, which can amplify near-term selling pressure.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $96.63 on Thursday. The firm has a market capitalization of $77.89 billion, a PE ratio of 36.88, a P/E/G ratio of 4.43 and a beta of 0.29. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The firm’s 50-day simple moving average is $86.68 and its 200 day simple moving average is $82.53. The company has a quick ratio of 0.27, a current ratio of 0.83 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter in the previous year, the business posted $0.91 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Jefferies Financial Group raised their price target on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. UBS Group increased their price objective on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. TD Cowen reiterated a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Finally, Citigroup raised their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $94.75.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 in the last 90 days. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.